US › Healthcare

Im Cannabis Corp (IMCC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.13+1.03%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$8.7M

Revenue YoY

-30.6%

Net profit

$-2.3M

Profit YoY

-928.0%

EPS

$-0.28

Net margin

-26.2%

Key statistics

Market cap

$1.1M

Forward P/E

42.4

P/B

0.95

Book value

$-0.58

EPS (TTM)

$-2.24

52-week high

$3.13

52-week low

$0.10

50-day MA

$0.19

200-day MA

$0.84

Beta

2.11

Analyst view

Analysts rate Im Cannabis Corp a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $8.22.

Shareholding

Insiders

35.15%

Institutions

0.46%

Largest institutional holders

Fund	Stake
Hidden Cove Wealth Management, LLC	0.16%
Bank of Montreal	0.13%
BMO Capital Markets Corp.	0.13%
Federation des caisses Desjardins du Quebec	0.02%
NATIONAL BANK OF CANADA /FI/	0.00%
Royal Bank of Canada	0.00%
Advisor Group Holdings, Inc.	0.00%
TD Waterhouse Canada Inc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Im Cannabis Corp — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.